Skip to main content
Erschienen in: Journal of Hematopathology 3/2020

31.07.2020 | Original Article

Histopathological and clinical features of nodular lymphocyte-predominant Hodgkin lymphoma and their impact on prognosis: first report from Iran

verfasst von: Ahmad Monabati, Akbar Safaei, Maral Mokhtari, Pardis Nematollahi, Marjan Faghih, Samaneh Boroumand-Noughabi

Erschienen in: Journal of Hematopathology | Ausgabe 3/2020

Einloggen, um Zugang zu erhalten

Abstract

Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) is a rare subtype of Hodgkin lymphoma (HL). It shows different histoarchitectural patterns which are reported to be of prognostic significance. This study aimed to investigate the clinicopathological features of NLPHL cases in Shiraz, Iran, and their possible impact on prognosis. Between March 2014 and November 2019, all records for lymphoma were extracted from the electronic files of hospitals affiliated with Shiraz University of Medical Sciences. The slides of all NLPHL cases were extracted and reviewed. Other necessary data was retrieved from hospital records and through direct contact with patients. Among1168 lymphoma cases, 382 were HLs and 19.1% (73) of them were of the NLPHL type. The median age of NLPHL patients was 34 years. Of the patients, 51.5% showed variant patterns, and 11% of them had BM involvement. The variant morphology was significantly associated with BM involvement (p = 0.02). Patients with higher stage tumors had lower OS and PFS rates. Stage, BM involvement, and infra-diaphragmatic involvement were significantly associated with outcomes. The rate of NLPHL and variant morphology seems to be high in our center in Iran. The variant morphology was associated with a higher BM involvement rate but not with OS or PFS. Higher stage, BM, and subdiaphragmatic disease involvement were associated with worse outcomes.
Literatur
1.
Zurück zum Zitat Bazzeh F, Rihani R, Howard S, Sultan I (2010) Comparing adult and pediatric Hodgkin lymphoma in the surveillance, epidemiology and end results program, 1988–2005: an analysis of 21 734 cases. Leuk Lymphoma 51:2198–2207CrossRef Bazzeh F, Rihani R, Howard S, Sultan I (2010) Comparing adult and pediatric Hodgkin lymphoma in the surveillance, epidemiology and end results program, 1988–2005: an analysis of 21 734 cases. Leuk Lymphoma 51:2198–2207CrossRef
2.
Zurück zum Zitat Thomas R, Re D, Zander T, Wolf J, Diehl V (2002) Epidemiology and etiology of Hodgkin’s lymphoma. Ann Oncol 13:147–152CrossRef Thomas R, Re D, Zander T, Wolf J, Diehl V (2002) Epidemiology and etiology of Hodgkin’s lymphoma. Ann Oncol 13:147–152CrossRef
3.
Zurück zum Zitat Hartmann S, Eichenauer DA (2020) Nodular lymphocyte predominant Hodgkin lymphoma: pathology, clinical course and relation to T-cell/histiocyte rich large B-cell lymphoma. Pathology 52:142–153CrossRef Hartmann S, Eichenauer DA (2020) Nodular lymphocyte predominant Hodgkin lymphoma: pathology, clinical course and relation to T-cell/histiocyte rich large B-cell lymphoma. Pathology 52:142–153CrossRef
4.
Zurück zum Zitat Anagnostopoulos I, Hansmann M-L, Franssila K, Harris M, Harris NL, Jaffe ES, Han J, van Krieken J, Poppema S, Marafioti T, Franklin J, Sextro M, Diehl V, Stein H (2000) European task force on lymphoma project on lymphocyte predominance Hodgkin disease: histologic and immunohistologic analysis of submitted cases reveals 2 types of Hodgkin disease with a nodular growth pattern and abundant lymphocytes. Blood 96:1889–1899PubMed Anagnostopoulos I, Hansmann M-L, Franssila K, Harris M, Harris NL, Jaffe ES, Han J, van Krieken J, Poppema S, Marafioti T, Franklin J, Sextro M, Diehl V, Stein H (2000) European task force on lymphoma project on lymphocyte predominance Hodgkin disease: histologic and immunohistologic analysis of submitted cases reveals 2 types of Hodgkin disease with a nodular growth pattern and abundant lymphocytes. Blood 96:1889–1899PubMed
5.
Zurück zum Zitat Stein H, Swerdlow SH, Gascoyne RD, Poppema S, Jaffe ES, Pileri SA (2017) Nodular lymphocyte predominant Hodgkin lymphoma. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J (eds) WHO classification of Tumours of Haematopoietic and lymphoid tissues, revised, 4th edn. IARC, Lyon, pp 431–434 Stein H, Swerdlow SH, Gascoyne RD, Poppema S, Jaffe ES, Pileri SA (2017) Nodular lymphocyte predominant Hodgkin lymphoma. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J (eds) WHO classification of Tumours of Haematopoietic and lymphoid tissues, revised, 4th edn. IARC, Lyon, pp 431–434
6.
Zurück zum Zitat Fan Z, Natkunam Y, Bair E, Tibshirani R, Warnke RA (2003) Characterization of variant patterns of nodular lymphocyte predominant Hodgkin lymphoma with immunohistologic and clinical correlation. Am J Surg Pathol 27:1346–1356CrossRef Fan Z, Natkunam Y, Bair E, Tibshirani R, Warnke RA (2003) Characterization of variant patterns of nodular lymphocyte predominant Hodgkin lymphoma with immunohistologic and clinical correlation. Am J Surg Pathol 27:1346–1356CrossRef
7.
Zurück zum Zitat Hartmann S, Eichenauer DA, Plütschow A, Mottok A, Bob R, Koch K, Bernd HW, Cogliatti S, Hummel M, Feller AC, Ott G, Möller P, Rosenwald A, Stein H, Hansmann ML, Engert A, Klapper W (2013) The prognostic impact of variant histology in nodular lymphocyte-predominant Hodgkin lymphoma: a report from the German Hodgkin Study group (GHSG). Blood 122:4246–4252CrossRef Hartmann S, Eichenauer DA, Plütschow A, Mottok A, Bob R, Koch K, Bernd HW, Cogliatti S, Hummel M, Feller AC, Ott G, Möller P, Rosenwald A, Stein H, Hansmann ML, Engert A, Klapper W (2013) The prognostic impact of variant histology in nodular lymphocyte-predominant Hodgkin lymphoma: a report from the German Hodgkin Study group (GHSG). Blood 122:4246–4252CrossRef
8.
Zurück zum Zitat Shankar AG, Kirkwood AA, Hall GW, Hayward J, O'Hare P, Ramsay AD (2015) Childhood and adolescent nodular lymphocyte predominant Hodgkin lymphoma-a review of clinical outcome based on the histological variants. Br J Haematol 171:254–262CrossRef Shankar AG, Kirkwood AA, Hall GW, Hayward J, O'Hare P, Ramsay AD (2015) Childhood and adolescent nodular lymphocyte predominant Hodgkin lymphoma-a review of clinical outcome based on the histological variants. Br J Haematol 171:254–262CrossRef
9.
Zurück zum Zitat Panjwani P, Epari S, Sengar M, Laskar S, Menon H, Shet T (2015) Bone marrow involvement in nodular lymphocyte predominant Hodgkin lymphoma occurs in tumors with a variant pattern. Leuk lymphoma 56:236–238CrossRef Panjwani P, Epari S, Sengar M, Laskar S, Menon H, Shet T (2015) Bone marrow involvement in nodular lymphocyte predominant Hodgkin lymphoma occurs in tumors with a variant pattern. Leuk lymphoma 56:236–238CrossRef
10.
Zurück zum Zitat Agbay RLMC, Loghavi S, Zuo Z, Fayad L, Dabaja B, Medeiros LJ, Khoury JD (2018) Bone marrow involvement in patients with nodular lymphocyte predominant Hodgkin lymphoma. Am J Surg Pathol 42:492–499CrossRef Agbay RLMC, Loghavi S, Zuo Z, Fayad L, Dabaja B, Medeiros LJ, Khoury JD (2018) Bone marrow involvement in patients with nodular lymphocyte predominant Hodgkin lymphoma. Am J Surg Pathol 42:492–499CrossRef
11.
Zurück zum Zitat Colby TV, Hoppe RT, Warnke RA (1982) Hodgkin’s disease: a clinicopathologic study of 659 cases. Cancer 49:1848–1858CrossRef Colby TV, Hoppe RT, Warnke RA (1982) Hodgkin’s disease: a clinicopathologic study of 659 cases. Cancer 49:1848–1858CrossRef
12.
Zurück zum Zitat Eladl AE, Satou A, Elsayed AA, Suzuki Y, Shimizu-Kohno K, Kato S, Tomita A, Kinoshita T, Nakamura S, Asano N (2015) Nodular lymphocyte predominant Hodgkin lymphoma: clinicopathological study of 25 cases from Japan with a reappraisal of tissue associated macrophages. Pathol Int 65:652–660CrossRef Eladl AE, Satou A, Elsayed AA, Suzuki Y, Shimizu-Kohno K, Kato S, Tomita A, Kinoshita T, Nakamura S, Asano N (2015) Nodular lymphocyte predominant Hodgkin lymphoma: clinicopathological study of 25 cases from Japan with a reappraisal of tissue associated macrophages. Pathol Int 65:652–660CrossRef
13.
Zurück zum Zitat Yang Q-P, Zhang W-Y, Yu J-B, Zhao S, Xu H, Wang W-Y, Bi CF, Zuo Z, Wang XQ, Huang J, Dai L, Liu WP (2011) Subtype distribution of lymphomas in Southwest China: analysis of 6,382 cases using WHO classification in a single institution. Diagn Pathol 6:77CrossRef Yang Q-P, Zhang W-Y, Yu J-B, Zhao S, Xu H, Wang W-Y, Bi CF, Zuo Z, Wang XQ, Huang J, Dai L, Liu WP (2011) Subtype distribution of lymphomas in Southwest China: analysis of 6,382 cases using WHO classification in a single institution. Diagn Pathol 6:77CrossRef
14.
Zurück zum Zitat Monabati A, Safaei A, Noori S, Mokhtari M, Vahedi A (2016) Subtype distribution of lymphomas in south of Iran, analysis of 1085 cases based on World Health Organization classification. Ann Hematol 95:613–618CrossRef Monabati A, Safaei A, Noori S, Mokhtari M, Vahedi A (2016) Subtype distribution of lymphomas in south of Iran, analysis of 1085 cases based on World Health Organization classification. Ann Hematol 95:613–618CrossRef
15.
Zurück zum Zitat Mozaheb Z, Aledavood A, Farzad F (2011) Distributions of major sub-types of lymphoid malignancies among adults in Mashhad, Iran. Cancer Epidemiol 35:26–29CrossRef Mozaheb Z, Aledavood A, Farzad F (2011) Distributions of major sub-types of lymphoid malignancies among adults in Mashhad, Iran. Cancer Epidemiol 35:26–29CrossRef
16.
Zurück zum Zitat Shamloo N, Ghannadan A, Jafari M, Ahmadi S, Mortazavi H, Baharvand M (2017) Head and neck lymphoma in an Iranian population. Iran J Otorhinolaryngol 29:261PubMedPubMedCentral Shamloo N, Ghannadan A, Jafari M, Ahmadi S, Mortazavi H, Baharvand M (2017) Head and neck lymphoma in an Iranian population. Iran J Otorhinolaryngol 29:261PubMedPubMedCentral
17.
Zurück zum Zitat Eichenauer DA, Plütschow A, Fuchs M, Sasse S, Baues C, Böll B, von Tresckow B, Diehl V, Borchmann P, Engert A (2020) Long-term follow-up of patients with nodular lymphocyte-predominant Hodgkin lymphoma treated in the HD7 to HD15 trials: a report from the German Hodgkin Study Group. J Clin Oncol 38:698–705CrossRef Eichenauer DA, Plütschow A, Fuchs M, Sasse S, Baues C, Böll B, von Tresckow B, Diehl V, Borchmann P, Engert A (2020) Long-term follow-up of patients with nodular lymphocyte-predominant Hodgkin lymphoma treated in the HD7 to HD15 trials: a report from the German Hodgkin Study Group. J Clin Oncol 38:698–705CrossRef
18.
Zurück zum Zitat Molin D, Linderoth J, Wahlin BE (2017) Nodular lymphocyte predominant Hodgkin lymphoma in Sweden between 2000 and 2014: an analysis of the Swedish Lymphoma Registry. Br J Haematol 177:449–456CrossRef Molin D, Linderoth J, Wahlin BE (2017) Nodular lymphocyte predominant Hodgkin lymphoma in Sweden between 2000 and 2014: an analysis of the Swedish Lymphoma Registry. Br J Haematol 177:449–456CrossRef
19.
Zurück zum Zitat Hartmann S, Plütschow A, Mottok A, Bernd HW, Feller AC, Ott G, Cogliatti S, Fend F, Quintanilla-Martinez L, Stein H, Klapper W, Möller P, Rosenwald A, Engert A, Hansmann ML, Eichenauer DA (2019) The time to relapse correlates with the histopathological growth pattern in nodular lymphocyte predominant Hodgkin lymphoma. Am J Hematol 94:1208–1213CrossRef Hartmann S, Plütschow A, Mottok A, Bernd HW, Feller AC, Ott G, Cogliatti S, Fend F, Quintanilla-Martinez L, Stein H, Klapper W, Möller P, Rosenwald A, Engert A, Hansmann ML, Eichenauer DA (2019) The time to relapse correlates with the histopathological growth pattern in nodular lymphocyte predominant Hodgkin lymphoma. Am J Hematol 94:1208–1213CrossRef
20.
Zurück zum Zitat Shivarov V, Ivanova M (2018) Nodular lymphocyte predominant Hodgkin lymphoma in USA between 2000 and 2014: an updated analysis based on the SEER data. Br J Haematol 182:727–730CrossRef Shivarov V, Ivanova M (2018) Nodular lymphocyte predominant Hodgkin lymphoma in USA between 2000 and 2014: an updated analysis based on the SEER data. Br J Haematol 182:727–730CrossRef
21.
Zurück zum Zitat Posthuma HL, Zijlstra JM, Visser O, Lugtenburg PJ, Kersten MJ, Dinmohamed AG (2020) Primary therapy and survival among patients with nodular lymphocyte-predominant Hodgkin lymphoma: a population-based analysis in the Netherlands, 1993–2016. Br J Haematol 189:117–121CrossRef Posthuma HL, Zijlstra JM, Visser O, Lugtenburg PJ, Kersten MJ, Dinmohamed AG (2020) Primary therapy and survival among patients with nodular lymphocyte-predominant Hodgkin lymphoma: a population-based analysis in the Netherlands, 1993–2016. Br J Haematol 189:117–121CrossRef
22.
Zurück zum Zitat Borchmann S, Joffe E, Moskowitz CH, Zelenetz AD, Noy A, Portlock CS, Gerecitano JF, Batlevi CL, Caron PC, Drullinsky P, Hamilton A, Hamlin PA Jr, Horwitz SM, Kumar A, Matasar MJ, Moskowitz AJ, Owens CN, Palomba ML, Younes A, Straus DJ (2019) Active surveillance for nodular lymphocyte-predominant Hodgkin lymphoma. Blood 133:2121–2129CrossRef Borchmann S, Joffe E, Moskowitz CH, Zelenetz AD, Noy A, Portlock CS, Gerecitano JF, Batlevi CL, Caron PC, Drullinsky P, Hamilton A, Hamlin PA Jr, Horwitz SM, Kumar A, Matasar MJ, Moskowitz AJ, Owens CN, Palomba ML, Younes A, Straus DJ (2019) Active surveillance for nodular lymphocyte-predominant Hodgkin lymphoma. Blood 133:2121–2129CrossRef
23.
Zurück zum Zitat Prasad M, Narula G, Chinnaswamy G, Arora B, Shet T, Panjwani P, Sengar M, Laskar S, Khanna N, Banavali S (2018) Unfavorable presentation but comparable outcome: presentation and outcome of children with nodular lymphocyte predominant Hodgkin lymphoma from India. Pediatr Blood Cancer 65:e27288CrossRef Prasad M, Narula G, Chinnaswamy G, Arora B, Shet T, Panjwani P, Sengar M, Laskar S, Khanna N, Banavali S (2018) Unfavorable presentation but comparable outcome: presentation and outcome of children with nodular lymphocyte predominant Hodgkin lymphoma from India. Pediatr Blood Cancer 65:e27288CrossRef
24.
Zurück zum Zitat Untanu RV, Back J, Appel B, Pei Q, Chen L, Buxton A, Hodgson DC, Ehrlich PF, Constine LS, Schwartz CL, Hutchison RE (2018) Variant histology, IgD and CD30 expression in low-risk pediatric nodular lymphocyte predominant Hodgkin lymphoma: a report from the Children’s Oncology Group. Pediatr Blood Cancer 65:e26753CrossRef Untanu RV, Back J, Appel B, Pei Q, Chen L, Buxton A, Hodgson DC, Ehrlich PF, Constine LS, Schwartz CL, Hutchison RE (2018) Variant histology, IgD and CD30 expression in low-risk pediatric nodular lymphocyte predominant Hodgkin lymphoma: a report from the Children’s Oncology Group. Pediatr Blood Cancer 65:e26753CrossRef
Metadaten
Titel
Histopathological and clinical features of nodular lymphocyte-predominant Hodgkin lymphoma and their impact on prognosis: first report from Iran
verfasst von
Ahmad Monabati
Akbar Safaei
Maral Mokhtari
Pardis Nematollahi
Marjan Faghih
Samaneh Boroumand-Noughabi
Publikationsdatum
31.07.2020
Verlag
Springer Berlin Heidelberg
Erschienen in
Journal of Hematopathology / Ausgabe 3/2020
Print ISSN: 1868-9256
Elektronische ISSN: 1865-5785
DOI
https://doi.org/10.1007/s12308-020-00410-y

Weitere Artikel der Ausgabe 3/2020

Journal of Hematopathology 3/2020 Zur Ausgabe

Neu im Fachgebiet Pathologie

Molekularpathologische Untersuchungen im Wandel der Zeit

Open Access Biomarker Leitthema

Um auch an kleinen Gewebeproben zuverlässige und reproduzierbare Ergebnisse zu gewährleisten ist eine strenge Qualitätskontrolle in jedem Schritt des Arbeitsablaufs erforderlich. Eine nicht ordnungsgemäße Prüfung oder Behandlung des …

Vergleichende Pathologie in der onkologischen Forschung

Pathologie Leitthema

Die vergleichende experimentelle Pathologie („comparative experimental pathology“) ist ein Fachbereich an der Schnittstelle von Human- und Veterinärmedizin. Sie widmet sich der vergleichenden Erforschung von Gemeinsamkeiten und Unterschieden von …

Gastrointestinale Stromatumoren

Open Access GIST CME-Artikel

Gastrointestinale Stromatumoren (GIST) stellen seit über 20 Jahren ein Paradigma für die zielgerichtete Therapie mit Tyrosinkinaseinhibitoren dar. Eine elementare Voraussetzung für eine mögliche neoadjuvante oder adjuvante Behandlung bei …

Personalisierte Medizin in der Onkologie

Aufgrund des erheblichen technologischen Fortschritts in der molekularen und genetischen Diagnostik sowie zunehmender Erkenntnisse über die molekulare Pathogenese von Krankheiten hat in den letzten zwei Jahrzehnten ein grundlegender …